M. YÜKSEL Et Al. , "Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?," 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , vol.54, Frankfurt, Germany, pp.505-506, 2019
YÜKSEL, M. Et Al. 2019. Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?. 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , (Frankfurt, Germany), 505-506.
YÜKSEL, M., CENGİZ SEVAL, G., Uslu, A., Kircili, E., KOYUN, D., Ozturk, C., ... Ozdemir, Z. N.(2019). Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT? . 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) (pp.505-506). Frankfurt, Germany
YÜKSEL, MELTEM Et Al. "Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?," 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 2019
YÜKSEL, MELTEM Et Al. "Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?." 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Frankfurt, Germany, pp.505-506, 2019
YÜKSEL, M. Et Al. (2019) . "Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?." 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Frankfurt, Germany, pp.505-506.
@conferencepaper{conferencepaper, author={MELTEM YÜKSEL Et Al. }, title={Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?}, congress name={45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)}, city={Frankfurt}, country={Germany}, year={2019}, pages={505-506} }